Categories
Tags
Abbott Advertising AstraZeneca Barack Obama Biotechnology and Pharmaceuticals Breast cancer Bristol Myers Squibb business Cancer Clinical trial Conditions and Diseases Deal Eli Lilly European Commission European Union FDA Food and Drug Administration Genentech generics GlaxoSmithKline Google GSK HBA Health Health care Johnson & Johnson layoffs Lilly Margaret Hamburg Marketing Merck Novartis Pfizer Pharma Pharmaceutical drug pharmaceutical industry Research and development Roche Sanofi-Aventis Schering Plough social media Twitter U.S. Food and Drug Administration United States Wyeth
Technology News
BioPharm News- Shire Gains European Approval for its Gaucher Disease Treatment
- Mtech Bioprocess Scale-Up Facility to Double in Staff and Size
- ImClone Closes Plant in New Jersey, Consolidating Erbitux Manufacture
- EMA and FDA Seek Applicants for Joint GMP Inspections
- ATMI Expands Bloomington, Minnesota Manufacturing Facility
Clinical Trials News- CRF Health Achieves EXACT ePRO Vendor Certification for Windows Mobile Systems
- ACR Image Metrix Establishes Global Presence
- BioPharm Systems Named to the 2010 Inc. 500|5000 List of Fastest-Growing Companies in the U.S.
- CRF Health Doubles North American Headquarters
- Oracle Completes Acquisition of Phase Forward
Blogroll
-
Meta
Tag Archives: Abbott
Saving Haiti: One Donation at a Time (UPDATED 1/21)
Image by American Red Cross via Flickr
It’s been less than three days since new broke of a massive earthquake in Haiti that all but leveled the struggling country. With thousands dead, a devastated infrastructure, and no emergency plan, countries and businesses around the world have joined in the effort to help the Haitian people with [...]
Posted in News Also tagged American Red Cross, Amgen, Emergency management, Haiti, Health care, Humanitarian aid, Lilly, Red Cross 1 Comment
Abbott to Purchase Solvay for $6.6 Billion (Update 1)
Abbott announced, early Monday morning, that it had signed a deal to purchase Belgium-based drug manufacturer Solvay Pharmaceuticals for $6.6 billion in cash—a mere five months after Solvay’s CEO Werner Cautreels announced that the company was searching for a proper suitor.
The deal adds more than $3 billion in annualized sales to its global pharmaceutical business—three-quarters [...]
AZ, Sepracor, and Abbott Cinch Belts With Layoffs
It’s been a tough few days for pharmaceutical employees. Just days after Pfizer announced that it would eliminate 10 percent of its workforce, three other companies are revealing restructuring plans that include releasing hundreds (and in one case thousands) of employees.
In its fourth quarter report released today, AstraZeneca stated that it will continue its “new [...]
The KOL Database Kingdom
Tracking interactions with KOLs can be a daunting task if you don’t have the right systems in place. Similar to the children’s mythology-themed boardgame, “Key to the Kingdom,” the odds of mastering it at first try are slim—but over time, you learn from mistakes, become familiar with the rules, and ultimately succeed.
Michael Schaffer, senior district [...]

Abbott Shells Out $3.7 Billion for Piramal